Locations:
Search IconSearch

Urology & Nephrology

Human Urinary System Kidneys Anatomy

Empagliflozin Is Safe and Effective in Patients With Chronic Kidney Disease

Cleveland Clinic nephrologist and site PI distills its significance and offers considerations

Aspirin

Study Sheds Light on Aspirin’s Effects in Chronic Kidney Disease, but Questions Remain

New retrospective analysis of clinical trial data provide some reassurance regarding the safety of aspirin in patients with CKD

650×450-Virtual-Reality-Nakhoul

How a Virtual Reality Tool Is Enhancing Renal Physiology Education

Findings about the tool's utility were presented at the American Society of Nephology’s 2022 Annual Meeting

R-Port Laparoscopic Trans BladderProstatectomy
October 26, 2022/Urology & Nephrology/Urology

Robotic Prostatectomy Without Ventilator General Anesthesia? A New Technique Is Making It a Reality

Single-port robot-assisted transvesical prostatectomy is enabling new approaches

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-CNR-3290544-CQD-Hero-prostate cancer 650×450
October 24, 2022/Cancer/Research

Study Reveals Gene Expression Patterns Associated With Aggressive Pathologic Features In Prostate Cancer

What is the role of molecular profiling in risk stratification?

Microscopic image showing adenocarcinoma of Prostate.
September 20, 2022/Cancer

In Search of Improved Risk Modeling for Cribriform, Intraductal Carcinoma of the Prostate

Can genomic classifiers contemporize stratification?

Machine learning

Machine Learning Bests Experts in Predicting Patient Response to Overactive Bladder Treatment

Algorithm aligns with subjective patient reports as well as objective outcomes

Sperm motility

Sperm Assessment Process Helps Predict Outcomes in Male Factor Fertility Challenges

Stratified sperm count and motility data informs IVF decision-making

BackPage 10 of 32Next

Advertisement

Ad